Korivi M.Wu C.-Y.KEH-CHUNG LIN2020-03-262020-03-2620130929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890179449&doi=10.1016%2fj.jfma.2013.10.017&partnerID=40&md5=bb8c76d7187a069539024a67400c45fbhttps://scholars.lib.ntu.edu.tw/handle/123456789/479168[SDGs]SDG3biological marker; C reactive protein; interleukin 10; interleukin 6; reactive oxygen metabolite; tumor necrosis factor alpha; biological marker; C reactive protein; interleukin derivative; aerobic capacity; Barthel index; cardiovascular disease; cardiovascular risk; cerebrovascular accident; constraint induced therapy; cytokine production; diabetes mellitus; dietary intake; functional magnetic resonance imaging; high risk population; human; inflammatory cell; metabolic syndrome X; outcome assessment; oxidative stress; predictive value; prevalence; prognosis; rehabilitation research; robotics; short survey; stroke patient; transcranial magnetic stimulation; blood; inflammation; metabolism; Stroke; treatment outcome; Biological Markers; C-Reactive Protein; Humans; Inflammation; Interleukins; Predictive Value of Tests; Stroke; Treatment Outcomejournal article10.1016/j.jfma.2013.10.017243261022-s2.0-84890179449